Like Pfizer, Roche sees US tax cut boosting 2018 profit

Berlin

ROCHE Holding AG said that US tax cuts for businesses will boost profit this year, offsetting the impact of the company's most significant transformation in decades.

Core earnings per share will grow by a percentage in the high single digits, the Basel, Switzerland-based company said in a statement on Thursday. That compares to a 5 per cent increase last year, when new medicines helped push Roche's profit to 15.34 Swiss francs (S$21.60) a share, less than analysts had estimated. Sales growth will slow this year.